Background Early detection to identify people at risk of diabetes is an important approach to prevent or delay type 2 diabetes. This study aimed to implement the Diabetes Prevention Program in community pharmacy using a diabetes risk prediction tool.
Introduction
Diabetes is one of the major public health problems which affects around 285 million patients worldwide (6.4% of adult population). The number of patients with diabetes is estimated to increase to 439 million by 2030. 1 In Thailand, the Thai National Health Examination Survey IV, 2009 revealed a prevalence of diabetes in the Thai population at 7.5%. 2 Interestingly, 35.4% of these patients with diabetes were not previously diagnosed. Undetected diabetes is generally due to the nature of the disease as most patients are asymptomatic during the early stage. 3 Over the past decade, studies have consistently shown that the development of type 2 diabetes can be prevented by lifestyle modification in high risk individuals, particularly those with pre-diabetes or in early stage of the disease. 4 -6 Early identification of people with pre-diabetes and undiagnosed diabetes is therefore an important approach to prevent type 2 diabetes. 7 Invasive blood glucose tests appear to be inconvenient and incur relatively high costs when administered as a screening test for diabetes at a population level. 8 To address these problems, a number of inexpensive and non-invasive methods have been developed as a practical screening tool to identify individuals at risk of diabetes. 9 -11 These simple tools use a few questions and straightforward measurement of anthropometric indexes to calculate a risk score for predicting a development of type 2 diabetes.
In Thailand, a risk score for predicting diabetes in the Thai population was developed using information from a 12-year cohort of 2677 individuals aged 35 -55 years. 12 The risk score was calculated based on a set of variables (detailed in Fig. 1 ). The total score ranged between 1 and 17 from low risk (,5% chance to become diabetic, score 2) to excessively high risk (.30% chance to become diabetic, score 11). A cut-off score of 9 yields a sensitivity of 76% and specificity of 74%. This tool was recommended by Thai Diabetes Management Guideline 2009 to be used to identify type 2 diabetes. 13 Community pharmacists are in a unique position and have successfully delivered screening services for diabetes. 14 -17 However, the screening protocol used in these studies varied widely and no previous study used a risk score calculation to identify patients at risk of diabetes. In addition, it has been suggested that screening should encompass individual explanations and advice on lifestyle modification in order to prevent type 2 diabetes. 18 However, few studies have incorporated educational programmes into community pharmacy screening service.
14, 15 We therefore conducted this study in order to implement Diabetes Prevention Program in community pharmacy using a diabetes risk prediction tool.
Materials and methods
This study was developed under a concept of pharmacy diabetes prevention program which incorporated a sequential risk prediction and screening for diabetes and individual education in accordance with his/her health risk. The diabetes risk score developed by Aekplakorn et al. 12 was used as a risk prediction tool to select high risk individuals for a subsequent fasting capillary blood glucose (CBG) test. Education provided by community pharmacists included the nature of diabetes and lifestyle modification, e.g. exercise, diet control and weight control. A convenience sample of seven accredited community pharmacies in Bangkok participated in the present study. This study was approved by the Institutional Review Board at Naresuan University, Phitsanulok, Thailand. All participants read the project information sheet and signed a consent form before undertaking the service.
Study preparations
Prior to the program, participating pharmacists attended a 1-day meeting to learn about the Diabetes Prevention Program as well as to refresh their knowledge in topics related to diabetes including epidemiology, pathophysiology, diagnosis, prevention and treatment options. Another half-day tutorial session was held shortly before launching the program in order to train participating pharmacists to use diabetes risk prediction and patient educational materials, which covered basic understanding about diabetes and preventive strategies including diet and exercise. All seven community pharmacies were provided with the same necessary equipment to assess diabetes risks, e.g. digital weight scales, automatic blood pressure (BP) monitor (Omron w HEM 7111) and capillary blood sugar monitor (Accu-chek Performa w ). The subject recruitment started in April 2011 and ended in August 2011.
Recruitment
The program campaign, i.e. informational signs and posters, were displayed in all seven pharmacies. Inclusion criteria for this study were subjects aged at least 35 years old who were interested in receiving the services. Exclusion criteria included the following: previous diagnosis of diabetes, current use of medications prescribed for treatment or prevention of diabetes. Subjects were recruited into the study either by pharmacist invitation or by self selection after observing the project informational signs and displays in the pharmacies. Pharmacists invited potentially eligible individuals to participate based on the pharmacist's judgment of the subject's age as generally it is considered culturally inappropriate to ask for someone's age in Thai culture. In addition, pharmacists asked the subjects if there were anyone in their household eligible for the study.
Implementation and data analysis
Interested participants met individually with the pharmacist. The pharmacist assessed the participants' risk of diabetes by using the diabetes risk prediction tool. Participants were asked about their age and family history. Weight, waist circumference and BP were measured. These data were used for calculating the diabetes risk score. If any participants had a high diabetes risk score (9), they were subsequently offered to come back and have a fasting CBG test at the pharmacies ( Fig. 1) . Participants with elevated fasting CBG (126 mg/dl) were referred to hospitals. Two follow-up telephone calls were made for those with elevated fasting CBG to check if they sought a confirmed diagnosis with medical practitioners.
All participants received educational information from pharmacists based on their diabetes risk score as suggested by the Thai Diabetes Management Guideline 2009. Educational materials developed for the study in the form of double-sided A4 folded leaflet for each topic, i.e. diabetes condition, exercise, weight reduction and diet control, were also provided for the participants accordingly. Those with a diabetes risk score of 5 were informed about lifestyle modification regarding exercise and weight reduction, whilst additional information on diet control was given to subjects with a diabetes risk score of 6. The risk assessment and educational services were provided free of charge as a 'value-added' service to customers of all seven community pharmacies.
The primary outcome was the number of participants with high risk of diabetes as identified by the diabetes risk score (9) . The secondary outcomes of interest were the number of high risk individuals undertaking a fasting CBG test within 2 weeks after knowing their diabetes risk score; *Blood pressure >140/90 mmHg or current prescription of blood pressure-lowering treatment 
Results
A total of 397 subjects participated in the program during a 3-month service in 7 community pharmacies. The mean age (+SD) was 50 (+10) years and 66.8% (265/397) of the participants were women (Table 1) . Body mass index (BMI) over 27.5 kg/m 2 and abdominal obesity (waist circumference of 90 in men or 80 cm in women) were found in 29.2 and 64.2% of the participants, respectively. About one third of the participants had high BP or treated hypertension (35.8%) and had a family history of diabetes (38.5%).
Nearly half of the participants (49.4%, 196/397) had a diabetes risk score of 9 (score: 9-10, 34.8%; score: 11, 14.6%), which was interpreted as having a very high and excessively high risk of diabetes (Table 2) . Ninety five (48.5%) out of those 196 participants with a diabetes risk score of 9 undertook fasting CBG tests at participating community pharmacies (Fig. 2) . Normoglycemia (fasting CBG: ,100 mg/dl) was observed in 56 persons (58.9%), pre-diabetes (fasting CBG: 100-125 mg/dl) in 27 persons (28.4%) and elevated fasting CBG (126 mg/dl) in 12 persons (12.7%).
While all 12 participants with suspicion of diabetes were recommended to seek a confirmed diagnosis from medical practitioners, only one has done so. However, this person was not diagnosed by a physician as having diabetes. Follow-up telephone calls have been made to all the remaining 11 persons, although 1 was not contactable. The main reason from 10 persons who failed to see medical practitioner was the inconvenience of making medical visit in a hospital setting.
Overall, a diagnosis of diabetes has been made by physicians for two participants. The first patient had typical signs of diabetes (10 kg weight loss in the past month and polyuria) despite having a risk score of only 2. A fasting CBG of 349 mg/dl was also observed and this patient was therefore referred to see a doctor. The second patient had elevated BP during his second visit to measure fasting CBG (reported at 117 mg/dl). This patient was advised by a pharmacist to seek medical supervision for his high BP. Elevated fasting plasma glucose was found during the hospital visit and this patient was subsequently diagnosed with diabetes.
Seventy-five participants (18.9%) who had a diabetes risk score between 3 and 5 received a recommendation for exercise and weight reduction from community pharmacists. They were also advised to take a further risk assessment every 1 -3 years as recommended by the Thai Diabetes Management Guideline 2009. Additional information on diet control was delivered to 279 participants (70.3%) with a risk score 6.
Discussion Main findings of this study
In developing countries such as Thailand, diabetes screening using blood glucose measurement is costly and may be 
What is already known on this topic
Numerous diabetes risk prediction tools for diabetes screening were developed in Western 9 -11 and Asian countries such as Oman, 19 India, 20 Japan, 21 and China. 22 However, these readily available tools have not been implemented in a community pharmacy setting. The feasibility and potential benefits of implementing a validated diabetes risk prediction tool shown in this study suggested that other countries could also achieve similar benefits in preventing the development of diabetes in community settings.
Considering a diabetes risk prediction tool for South-East Asian countries, the only existing tools were developed by two groups of Thai researchers, namely Aekplakorn et al. 12 and Keesukphan et al., 23 which calculated the diabetes risk score based on only three variables, i.e. age, BMI and known history of hypertension. Among these, Aekplakorn's risk prediction tool has been evaluated and shown to be the most effective tool, based on the highest area under the curve, to identify pre-diabetes. 24 We therefore employed Aekplakorn's risk prediction tool in our study. Given the simplicity and validity of the tool, the incorporation of this diabetes risk prediction tool as part of sequential screening process would be potentially feasible. The Diabetes Prevention Program, using this risk prediction tool, could be considered for implementation in community pharmacy settings for countries with similar contexts, like those in South-East Asia.
Another group of Thai researchers have employed Aekplakorn's risk prediction tool in a community pharmacy setting. 25 However, this tool was used as a supplementary screening method rather than criteria for sequential screening to identify individuals who would benefit most from CBG. Blood glucose measurement was still performed in all participants instead of being limited to those with high risk scores as recommended by Aekplakorn et al. 26 and the Thai Diabetes Management Guideline 2009. 13 
What this study adds
In this study, those with ,20% risk of diabetes in 12 years (score: 8) were not offered a CBG test. According to these criteria, the proportion of individuals who can avoid CBG measurement (50.6%) in our study is relatively high compared with others who conducted a sequential screening with a simple risk assessment criteria, i.e. 2.3% in the Swiss study by Hersberger et al., 15 and 22% in the Australian study by Krass et al. 16 This is due to differences in the prevalence of risk factors and the risk assessment criteria used across the three studies. Another explanation is possibly due to the minimal cut-off number of risk factors used in those previous studies, i.e. more than one 16 or two 15 risk factors, which may result in a very high proportion of participants eligible for blood glucose measurement.
The proportion of high risk participants who have successfully undertaken fasting CBG test found in this study (48.5%, 95/196) appeared similar to that reported in the Swiss study (46.6%). 15 Although a higher proportion was shown in the Australian study (80.6%), this was an overall figure of both fasting and random CBG tests. 16 Nevertheless, only fasting blood glucose was used in this study as it is recommended by the American Diabetes Association as a test for diabetes or for the assessment of risk of future diabetes, whilst a random CBG test was recommended when used in patient with classic symptoms of hyperglycemia. 27 Since not all participants with a high risk score developed symptoms of hyperglycemia, we therefore believed that they were less likely to benefit from a random CBG test.
Even though the sequential screening scheme in this study failed to discover a new case of diabetes, a total of two patients with diabetes were eventually identified through the provision of this service. This resulted in 0.5% (2/397) overall yield of the program which was slightly lower than that from an Australian study (1.7%), 16 but appeared at a similar rate with a screening service in community-based (0.5%) 28 and primary care (0.6%) 29 or general practice settings (0.8%). 30 The yield of screening in this study could be improved if all 12 participants with fasting CBG 126 mg/dl visited medical practitioners as recommended.
It has been suggested that knowing the result of blood glucose test is more convincing and may have an impact on individuals' perception of risk and subsequent behavior to uptake the referral. 16 However, findings in this study differed from the above assumption as a large proportion of participants with suspicion of diabetes refused to see the physicians (91.7%, 11/12) despite having been informed about their elevated CBG and received a reminder follow-up calls twice within 2 weeks. The training for participating pharmacists focused mainly on the condition of diabetes and lifestyle modification with little emphasis on effective approaches to patient education and behavior change. This might partly explain the low uptake rate identified in this study. By taking this into account, we suggested that training on effective approaches to patient education/behavior change should be incorporated in preparation session for pharmacists before performing health promotion service.
Although the inconvenience to access to healthcare services was reported as the barrier to seek medical supervision in most of those individuals, other potential obstacles should be explored and addressed to encourage them to seek appropriate medical care. Further study using a qualitative approach such as focus groups is needed in order to get a better understanding of the obstacles and promoting factors for those high risk individuals who failed to uptake the CBG test or seek medical practitioner. It should also be noted that community pharmacy is not formally integrated as part of the healthcare services system in Thailand, which may partly explain the negligible success rate of pharmacy referral found in this study.
Although a participant survey was not part of this research study, a questionnaire survey to evaluate the perception of the program was pilot tested in a small group of participants (43 persons). This preliminary survey demonstrated that most respondents appreciated the service and thought that it improved their attention to diabetes (86.1%), and gave them more confidence in preventing diabetes (90.7%) (results not shown). This suggested that, in addition to identifying persons with high risk of diabetes, the Diabetes Prevention Program also offered participants an opportunity to gain knowledge about the disease as well as information on lifestyle modification tailoring to their underlying risks. Consistent with other published literatures, 14 -17,31,32 findings from the Diabetes Prevention Program in this study illustrated that community pharmacists are in an ideal position to support health prevention in community settings by screening and educating individuals at risk of diabetes.
Limitations
The subjects recruited were limited to Bangkok where the prevalence of risk factors and the convenience in access to healthcare services may be different from other parts of Thailand. In addition, all seven community pharmacies selected to provide the service were accredited pharmacies, presumably providing high quality pharmacy services, hence the results may not be generalizable to other pharmacies. Selection bias may have emerged as those who felt at risk were more likely to participate in the study. In addition, the only protocol used for pharmacist to invite individuals to participate in the study was the subjects' age which was determined by pharmacist's judgment based on their appearance. It was therefore important to note that the judgment of the subject's age could vary between pharmacists. However, this deemed to be tolerable considering the fact that this study aimed to implement the screening service and provided an opportunity to the general population to assess to such service regardless of their perceptive baseline risk. Lastly, the impact of education on the behavior of the participants was not measured in the present study.
This study is the first to incorporate a diabetes risk prediction tool as a screening method to support the health prevention role of community pharmacists. Findings indicated that a diabetes prevention program using a validated risk prediction tool can be implemented in community pharmacies. However, to achieve a higher yield of screening, appropriate strategies should be used to encourage those with suspicion of diabetes to seek further medical supervision. Given the simplicity and validity of the tool and the potential benefits shown in our study, we recommend it as a sequential screening method to be used as part of the Diabetes Prevention Program provided by community pharmacists in Thailand. This Diabetes Prevention Program could be considered for implementation in community pharmacies in other countries, particularly those having an existing diabetes risk prediction tool.
